PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.88%
Revenue growth above 1.5x 3088.T's 2.29%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
5.75%
Positive gross profit growth while 3088.T is negative. John Neff would see a clear operational edge over the competitor.
12.67%
Positive EBIT growth while 3088.T is negative. John Neff might see a substantial edge in operational management.
12.67%
Positive operating income growth while 3088.T is negative. John Neff might view this as a competitive edge in operations.
-3.27%
Negative net income growth while 3088.T stands at 36.14%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-3.27%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-3.27%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.00%
Share reduction while 3088.T is at 1.64%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3088.T is at 1.66%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Dividend reduction while 3088.T stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.34%
10Y revenue/share CAGR under 50% of 3088.T's 100.78%. Michael Burry would suspect a lasting competitive disadvantage.
48.58%
5Y revenue/share CAGR at 75-90% of 3088.T's 62.61%. Bill Ackman would encourage strategies to match competitor’s pace.
25.30%
3Y revenue/share CAGR under 50% of 3088.T's 53.26%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.18%
Below 50% of 3088.T's 290.48%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
39.74%
5Y net income/share CAGR 1.25-1.5x 3088.T's 35.03%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
28.36%
3Y net income/share CAGR 1.25-1.5x 3088.T's 19.68%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
151.08%
10Y equity/share CAGR at 50-75% of 3088.T's 297.41%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
101.86%
5Y equity/share CAGR at 50-75% of 3088.T's 142.10%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
50.02%
Below 50% of 3088.T's 115.48%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
35.35%
Our AR growth while 3088.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-2.20%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.82%
Positive asset growth while 3088.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
2.57%
Positive BV/share change while 3088.T is negative. John Neff sees a clear edge over a competitor losing equity.
-57.60%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
83.47%
SG&A growth well above 3088.T's 31.18%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.